Welcome to Library
Annual Reports
RMRIMS News Bulletine
Publications List of Mr. Rakesh Bihari Verma


Rabi Das VN, Siddiqui NA, Pal B, Lal CS, Verma N, Kumar A, Verma RB, Kumar D, Das P and Pandey K. To evaluate efficacy and safety of amphotericin B in two different doses in the treatment of post kala-azar dermal leishmaniasis (PKDL). PLoS One. 2017 Mar 29;12(3):e0174497. doi: 10.1371/journal.pone.0174497. eCollection 2017.
Pandey K, Pal B, Das VN, Murti K, Lal CS, Verma N, Bimal S, Ali V, Verma RB, Topno RK, Siddiqi NA and Das P. Safety and efficacy of a combination of Paromomycin and Miltefosine for two versus three courses in patients with Post Kala-Azar Dermal Leishmaniasis (PKDL) - an observational pilot Study. Br J Dermatol. 2017; 177(2):557-559. doi: 10.1111/bjd.15119. Epub 2017 Jul 2.
Paswan RK, Bimal S, Kumari A, Sinha P, Das VN, Pandey K, Kumar S, Verma RB, Das P and Lal CS. Reduced High Density Lipoprotein Concentration Modulates Increased Interleukin-10 and Decreased Interferon-Gamma in Visceral Leishmaniasis Patients. Gen Med (Los Angel) 2016; 4:233. doi:10.4172/2327-5146.1000233.


Siddiqui NA, Rabidas VN, Sinha SK, Verma RB, Pandey K, Singh VP, Ranjan A, Topno RK, Lal CS, Kumar V, Sahoo GC, Sridhar S, Pandey A and Das P. Snowball Vs. House-to-House Technique for Measuring Annual Incidence of Kala-azar in the Higher Endemic Blocks of Bihar, India: A Comparison. PLoS Negl Trop Dis. 2016; 10(9): e0004970. doi: 10.1371/journal.pntd.0004970.


Das VN, Pandey RN, Kumar V, Pandey K, Siddiqui NA, Verma RB, Matlashewski G and Das P. Repeated training of accredited social health activists (ASHAs) for improved detection of visceral leishmaniasis cases in Bihar, India. Pathog Glob Health. 2016; 110(1): 33-35. doi: 10.1080/20477724.2016.1156902.


Pandey K, Ravidas V, Siddiqui NA, Sinha SK, Verma RB, Singh TP, Dhariwal AC, Das Gupta RK and Das P. Pharmacovigilance of Miltefosine in Treatment of Visceral Leishmaniasis in Endemic Areas of Bihar, India. Am J Trop Med Hyg. 2016; 95(5): 1100-1105.


Lal CS, Verma RB, Verma N, Siddiqui NA, Rabidas VN, Pandey K, Singh D, Kumar S, Paswan RK, Kumari A, Sinha P and Das P. Hypertriglyceridemia: a possible diagnostic marker of disease severity in visceral leishmaniasis. Infection. 2016; 44(1): 39-45. doi: 10.1007/s15010-015-0811-9. (Epub 2015 Jul 10).


Singh D, Pandey K, Das VN, Das S, Verma N, Ranjan A, Lal CS, Topno KR, Singh SK, Verma RB, Kumar A, Sardar AH, Purkait B and Das P. Evaluation of rK-39 Strip Test Using Urine for Diagnosis of Visceral Leishmaniasis in an Endemic Region of India.  Am Am J Trop Med Hyg. 2013; 88(2): 222-226. doi: 10.4269/ajtmh.2012.12-0489. (Epub 2012 Nov 13).


Lal CS, Kumar S, Ranjan A, Rabidas VN, Verma N, Pandey K, Verma RB, Das S, Singh D and Das P. Comparative analysis of serum zinc, copper, magnesium, calcium and iron level in acute and chronic patients of visceral leishmaniasis. J Trace Elem Med Biol. 2013; 27(2): 98-102. doi: 10.1016/j.jtemb.2012.09.007. (Epub 2012 Nov 28).


Verma N, Lal CS, Rabidas V, Pandey K, Singh D, Kumar S, Verma RB and Das P. Microalbuminuria and glomerular filtration rate in paediatric visceral leishmaniasis. Biomed Res Int. 2013; 2013: 498918. doi: 10.1155/2013/498918. (Epub 2013 Jun 23).


Verma N, Singh D, Pandey K, Das VN, Lal CS, Verma RB, Sinha PK and Das P. Comparative Evaluation of PCR and Imprint Smear Microscopy of Skin Biopsy in Diagnosis of Macular, Papular and Mixed Papulo-nodular Lesions of PKDL. J Clin Microbiol. 2013; 51(12): 4217-4219. doi: 10.1128/JCM.01482-13. (Epub 2013 Sep 25).


Pandey K, Das VN, Singh D, Das S, Lal CS, Verma N, Bimal S, Topno RK, Siddiqui NA, Verma RB, Sinha PK and Das P. Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in India. J Clin Microbiol. 2012; 50(4): 1478-1479. (Epub 2012 Jan 25).


Das VNR, Ranjan A, Pandey K, Singh D, Verma N, Das S, Lal CS, Sinha NK, Verma RB, Siddiqui NA, and Das P. Clinical epidemiologic profile of a cohort of post-kala-azar dermal leishmaniasis patients in Bihar, India.  Am. J. Trop. Med. Hyg., 2012; 86(6): 959–961.


Kumar N, Sinha PK, Pandey K, Verma N, Lal CS, Ranjan A, Verma RB and Das P. A rare case of Visceral leishmaniasis with multiple relapse and multi-drug unresponsive: successfully treated with combination therapy. Int J Clin Pharm. 2011; 33(5): 726-729. doi: 10.1007/s11096-011-9544-8. ( Epub 2011 Jul 22).


Das VN, Siddiqui NA, Verma RB, Topno RK, Singh D, Das S, Ranjan A, Pandey K, Kumar N and Das P. Asymptomatic infection of visceral leishmaniasis in hyperendemic areas of Vaishali district, Bihar, India: a challenge to kala-azar elimination programmes. Trans R Soc Trop Med Hyg, 2011; 105(11): 661-666. (Epub 2011 Sep 25).


Siddiqui NA, Kumar N, Ranjan A, Pandey K, Das VNR, Verma RB and Das P. Awareness about Kala-azar disease and related preventive attitudes and practices in a highly endemic rural area of India.  Southeast Asian J Trop Med Public Health, 2010; 41(1): 1-12.


Singh VP, Ranjan A, Topno RK, Verma RB, Siddique NA, Ravidas VN, Kumar N, Pandey K and Das P. Estimation of under reporting of Visceral Leishmaniasis cases in Bihar, India. American Journal of Tropical Medicine Hygiene, 2010; 82(1): 9-11.


Lal CS, Verma N, Rabidas VN, Ranjan A, Pandey K, Verma RB, Singh D, Kumar S and Das P. Total serum cholesterol determination can provide understanding of parasite burden in patients with visceral leishmaniasis infection. Clin Chim Acta. 2010; 411(23-24): 2112-2113. (Epub 2010 Sep 8).


Das VN, Pandey K, Verma N, Lal CS, Bimal S, Topno RK, Singh D, Siddiqui NA, Verma RB and Das P. Development of Post Kala-Azar Dermal Leishmaniasis (PKDL) in Miltefosinetreated visceral leishmaniasis. American Journal of Tropical Medicine and Hygiene, 2009; 80(3): 336-338.


Das VN, Siddiqui NA, Pandey K, Singh VP, Topno RK, Singh D, Verma RB, Ranjan A, Sinha PK and Das P. A controlled, randomized nonblinded clinical trial to assess the effi cacy of  mphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India. Therapeutics and Clinical Risk Management, 2009; 5: 117–124.


Kumar N, Siddiqui NA, Verma RB and Das P. Knowledge About Sandflies in Relation to Public and Domestic Control Activities of Kala-azar in Rural Endemic Areas of Bihar. Journal of Communicable Diseases, 2009, 41(2): 121-128.



Pandey k, Sinha PK, Das VN, Nawin Kumar, Bimal S, Verma RB, Verma N, Lal CS, Topno RK, Siddiqui NA, Singh D and Das P. Tuberous sclerosis with visceral leishmaniasis: a case report. Journal of Medical Case Reports, 2009; 3: 9027.


Sinha PK, Bimal S, Pandey K, Singh SK, Ranjan A, Kumar N, Lal CS, Barman SB, Verma RB, Jeyakumar A, Das P, Bhattacharya M, Sur D and Bhattacharya SK. A community-based, comparative evaluation of direct agglutination and rK39 strip tests in the early detection of subclinical Leishmania donovani infection. Ann Trop Med Parasitol, 2008; 102(2): 119-25.


Topno RK, Pandey K, Das VN, Kumar N, Bimal S, Verma RB, Siddiqui NA, Singh D, Kumar R, Kumar P, Ranjan A, Das P and Sinha PK. Visceral Leishmaniasis in pregnancy – role of Amphotericin B. Ann. Trop. Med. & Parasitol, 2008; 102(3): 267-270.


Bhattacharya SK, Sinha PK, Sundar S, Thakur CP, Jha TK, Pandey K, Das VR, Kumar N, Lal C, Verma N, Singh VP, Ranjan A, Verma RB, Anders G, Sindermann H and Ganguly NK. Phase IV Trial of Miltefosine in the Treatment of Indian Visceral Leishmaniasis. J Infect Dis, 2007;196(4): 591-598.


Pandey K, Sinha PK, Das VN, Kumar N, Verma N, Bimal S, Lal CS, Topno RK, Singh D, Verma RB, Bhattacharya SK and Das P. Wilson Disease with Visceral Leishmaniasis: An Extremely Uncommon Presentation. Am J Trop Med Hyg, 2007; 77(3): 560 – 561.


Das VN, Siddiqui NA, Kumar N, Verma N, Verma RB, Dinesh DS, Kar SK and Das P . A pilot study on the status of lymphatic filariasis in a rural community of Bihar. J Commun Dis, 2006; 38(2): 169-75.


Kumar N, Siddiquiu NA, Verma RB, Rabidas VNR, Verma N and Kar SK . A pilot study on mother's knowledge and their perception about control, transmission and treatment of Lymphatic Filariasis in a rural community of Bihar. Journal of Parasitic Diseases, 2003; 27: 33-37.



Kumar N, Siddiqui NA, Verma R and Kar S.K. Women's perceptions on kala-azar. Journal of Parasitic Disease. 2002; 26: 38-41.



Palit A, Kesari S, Kishore K, Kumar V, Dinesh DS, Ranjan A, Verma RB and Kar SK. Life budget analysis of phlebotomus papatasiscopoli (Diptera: psychodisae)a suspected vector of kala-azar in India. Journal of Parasitic Disease, 2000; 24: 87-88.